AP
Advisor Partners Portfolio holdings
AUM
$1.42B
This Quarter Return
+10.34%
1 Year Return
-3.97%
3 Year Return
+63.85%
5 Year Return
+114.32%
10 Year Return
–
AUM
$1.17B
AUM Growth
+$1.17B
(+8.6%)
Cap. Flow
+$70.9M
Cap. Flow
% of AUM
6.08%
Top 10 Holdings %
Top 10 Hldgs %
26.4%
Holding
723
New
39
Increased
346
Reduced
307
Closed
24
Top Buys
| 1 |
Apple
AAPL
|
$65.7M |
| 2 |
Berkshire Hathaway Class B
BRK.B
|
$1.35M |
| 3 |
Pfizer
PFE
|
$1.04M |
| 4 |
ORIX
IX
|
$741K |
| 5 |
Consolidated Edison
ED
|
$661K |
Top Sells
| 1 |
Gilead Sciences
GILD
|
$1.3M |
| 2 |
Intel
INTC
|
$1.26M |
| 3 |
Cisco
CSCO
|
$1.15M |
| 4 |
Citigroup
C
|
$1.12M |
| 5 |
Exxon Mobil
XOM
|
$1.05M |
Sector Composition
| 1 | Technology | 24.4% |
| 2 | Healthcare | 14.52% |
| 3 | Financials | 13.63% |
| 4 | Consumer Discretionary | 10.57% |
| 5 | Communication Services | 9.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Prudential Financial
PRU
$38.6B
| $2.24M | 0.19% |
35,276
-73
| -0.2% | -$4.64K |
|
102
Morgan Stanley
MS
$240B
| $2.23M | 0.19% |
46,046
+381
| +0.8% | +$18.4K |
|
103
AstraZeneca
AZN
$248B
| $2.16M | 0.19% |
39,447
+2,129
| +6% | +$117K |
|
104
Northrop Grumman
NOC
$84.5B
| $2.15M | 0.18% |
6,801
-148
| -2% | -$46.7K |
|
105
Equinix
EQIX
$76.9B
| $2.14M | 0.18% |
2,820
+36
| +1% | +$27.4K |
|
106
CME Group
CME
$96B
| $2.09M | 0.18% |
12,508
+928
| +8% | +$155K |
|
107
L3Harris
LHX
$51.9B
| $2.09M | 0.18% |
12,306
-159
| -1% | -$27K |
|
108
Biogen
BIIB
$19.4B
| $2.09M | 0.18% |
7,349
-30
| -0.4% | -$8.51K |
|
109
Vertex Pharmaceuticals
VRTX
$100B
| $2.07M | 0.18% |
7,609
-201
| -3% | -$54.7K |
|
110
TJX Companies
TJX
$152B
| $2.06M | 0.18% |
37,069
+1,094
| +3% | +$60.9K |
|
111
Becton Dickinson
BDX
$55.3B
| $2.04M | 0.17% |
8,744
-616
| -7% | -$143K |
|
|
112
Gilead Sciences
GILD
$140B
| $2.03M | 0.17% |
32,080
-20,545
| -39% | -$1.3M |
|
113
ASML
ASML
$292B
| $2.02M | 0.17% |
5,481
+143
| +3% | +$52.8K |
|
114
Progressive
PGR
$145B
| $2M | 0.17% |
21,080
+129
| +0.6% | +$12.2K |
|
115
PNC Financial Services
PNC
$81.7B
| $1.98M | 0.17% |
18,005
+347
| +2% | +$38.1K |
|
116
Southern Company
SO
$102B
| $1.97M | 0.17% |
36,346
-2,646
| -7% | -$143K |
|
117
Edwards Lifesciences
EW
$47.8B
| $1.97M | 0.17% |
24,667
+3,038
| +14% | +$243K |
|
118
Weyerhaeuser
WY
$18.7B
| $1.96M | 0.17% |
68,616
-892
| -1% | -$25.4K |
|
119
Cigna
CI
$80.3B
| $1.95M | 0.17% |
11,517
-2,656
| -19% | -$450K |
|
120
Stryker
SYK
$150B
| $1.95M | 0.17% |
9,334
+273
| +3% | +$56.9K |
|
121
Automatic Data Processing
ADP
$123B
| $1.94M | 0.17% |
13,885
+74
| +0.5% | +$10.3K |
|
122
Intuitive Surgical
ISRG
$170B
| $1.93M | 0.17% |
2,722
-22
| -0.8% | -$15.6K |
|
123
Novo Nordisk
NVO
$251B
| $1.93M | 0.17% |
27,818
+929
| +3% | +$64.5K |
|
124
Aon
AON
$79.1B
| $1.92M | 0.16% |
9,316
-291
| -3% | -$60K |
|
125
Booking.com
BKNG
$181B
| $1.92M | 0.16% |
1,121
-19
| -2% | -$32.5K |
|